Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Grant of Options

28th Oct 2010 14:58

RNS Number : 1840V
Cellcast plc
28 October 2010
 



28 October 2010

 

Cellcast plc

("Cellcast" or the "Company")

 

Grant of Options

 

Cellcast plc (AIM:CLTV) announces that the Board has today granted 1,050,000 options over ordinary 1p shares in the Company to the following Directors of Cellcast (the "Director Options"):

 

Name of Director

Number of Director Options granted

Andrew Wilson (CEO)*

450,000

Emmanuelle Guicharnaud (Finance Director)*

50,000

Bertrand Folliet (COO)

450,000

Julian Paul (Non-Executive Chairman)

50,000

Mike Neville (Non-Executive Director)

50,000

 

\* The Director Options granted to Andrew Wilson and Emmanuelle Guicharnaud have been granted under the Company's EMI Scheme and the balance of the Director Options have been granted under the Company's Share Option Plan.

 

The Director Options have been issued at an exercise price of 4p. Half of the Director Options are exercisable after a period of one year from issue and the other half are exercisable after a period of two years from issue.

 

The Company has also reallocated a further 850,000 existing options over ordinary 1p shares to other key technical and commercial members of staff (the "Staff Options"). The Staff Options are a reallocation of options granted to members of staff in July 2008 and have an exercise price of 4p. Half of the Staff Options are exercisable after a period of one year from issue and the other half are exercisable after a period of two years from issue.

 

Both the Director Options and the Staff Options have an expiry date of 10 years from the date of issue.

 

For further information contact:

 

Cellcast plc

Andrew Wilson, CEO

Tel: +44 (0) 20 7190 0300

[email protected]

 

www.cellcast.tv

Allenby Capital Limited

Nick Naylor / James Reeve

Tel: +44 (0) 20 3328 5656

[email protected]

www.allenbycapital.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSPGGUGUUPUGPR

Related Shares:

VITA.L
FTSE 100 Latest
Value8,275.66
Change0.00